Secretin treatment for autistic disorder: a critical analysis (Q34748848)

4 August 2017

1 reference

title

Secretin treatment for autistic disorder: a critical analysis (English)

1 reference

4 August 2017

0 references

4

M Lynn Crismon

1 reference

4 August 2017

Nick C Patel

1

1 reference

4 August 2017

Jun Y Yeh

series ordinal

2

1 reference

4 August 2017

Marvin D Shepherd

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

22

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

905-914

1 reference

Studies in the Childhood Psychoses I. Diagnostic Criteria and Classification

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Diagnosis and definition of childhood autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Autism and genetics. A decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Brief report: alternative approaches to the development of effective treatments for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Is there a basis for novel pharmacotherapy of autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Gastrointestinal abnormalities in children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Secretin and autism: a two-part clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Multisite, double-blind, placebo-controlled trial of porcine secretin in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Homeopathic Secretin in autism: a clinical pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

Placebo effects in autism: lessons from secretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.11.905.33622

10.1592/PHCO.22.11.905.33622

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference